Literature DB >> 22764608

Oculo-vestibular recoupling using galvanic vestibular stimulation to mitigate simulator sickness.

Michael J Cevette1, Jan Stepanek, Daniela Cocco, Anna M Galea, Gaurav N Pradhan, Linsey S Wagner, Sarah R Oakley, Benn E Smith, David A Zapala, Kenneth H Brookler.   

Abstract

INTRODUCTION: Despite improvement in the computational capabilities of visual displays in flight simulators, intersensory visual-vestibular conflict remains the leading cause of simulator sickness (SS). By using galvanic vestibular stimulation (GVS), the vestibular system can be synchronized with a moving visual field in order to lessen the mismatch of sensory inputs thought to result in SS.
METHODS: A multisite electrode array was used to deliver combinations of GVS in 21 normal subjects. Optimal electrode combinations were identified and used to establish GVS dose-response predictions for the perception of roll, pitch, and yaw. Based on these data, an algorithm was then implemented in flight simulator hardware in order to synchronize visual and GVS-induced vestibular sensations (oculo-vestibular-recoupled or OVR simulation). Subjects were then randomly exposed to flight simulation either with or without OVR simulation. A self-report SS checklist was administered to all subjects after each session. An overall SS score was calculated for each category of symptoms for both groups.
RESULTS: The analysis of GVS stimulation data yielded six unique combinations of electrode positions inducing motion perceptions in the three rotational axes. This provided the algorithm used for OVR simulation. The overall SS scores for gastrointestinal, central, and peripheral categories were 17%, 22.4%, and 20% for the Control group and 6.3%, 20%, and 8% for the OVR group, respectively.
CONCLUSIONS: When virtual head signals produced by GVS are synchronized to the speed and direction of a moving visual field, manifestations of induced SS in a cockpit flight simulator are significantly reduced.

Entities:  

Mesh:

Year:  2012        PMID: 22764608     DOI: 10.3357/asem.3239.2012

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  8 in total

1.  Reduction of cybersickness during and immediately following noisy galvanic vestibular stimulation.

Authors:  Séamas Weech; Travis Wall; Michael Barnett-Cowan
Journal:  Exp Brain Res       Date:  2020-01-14       Impact factor: 1.972

2.  Development of a conversion model between mechanical and electrical vestibular stimuli.

Authors:  A Chen; N Khosravi-Hashemi; C Kuo; J K Kramer; J-S Blouin
Journal:  J Neurophysiol       Date:  2019-12-18       Impact factor: 2.714

3.  Galvanic vestibular stimulation as a novel treatment for seasickness.

Authors:  Yoni Evgeni Gutkovich; Daniel Lagami; Anna Jamison; Yuri Fonar; Dror Tal
Journal:  Exp Brain Res       Date:  2021-11-15       Impact factor: 1.972

4.  Comparison of postural responses to galvanic vestibular stimulation between pilots and the general populace.

Authors:  Yang Yang; Fang Pu; Xiaoning Lv; Shuyu Li; Jing Li; Deyu Li; Minggao Li; Yubo Fan
Journal:  Biomed Res Int       Date:  2015-01-06       Impact factor: 3.411

5.  Influence of bone-conducted vibration on simulator sickness in virtual reality.

Authors:  Séamas Weech; Jae Moon; Nikolaus F Troje
Journal:  PLoS One       Date:  2018-03-28       Impact factor: 3.240

6.  Stroboscopic lighting with intensity synchronized to rotation velocity alleviates motion sickness gastrointestinal symptoms and motor disorders in rats.

Authors:  Yuqi Mao; Leilei Pan; Wenping Li; Shuifeng Xiao; Ruirui Qi; Long Zhao; Junqin Wang; Yiling Cai
Journal:  Front Integr Neurosci       Date:  2022-07-28

7.  Estimating the sensorimotor components of cybersickness.

Authors:  Séamas Weech; Jessy Parokaran Varghese; Michael Barnett-Cowan
Journal:  J Neurophysiol       Date:  2018-07-25       Impact factor: 2.714

8.  Joint and individual effectiveness of galvanic cutaneous stimulation and tactile stimulation at decreasing Simulator Adaptation Syndrome.

Authors:  Germán Gálvez-García; Javier Albayay; Fernando Fonseca; Claudio Bascour-Sandoval
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.